CalciMedica Inc.

NASDAQ: CALC · Real-Time Price · USD
2.87
0.26 (9.96%)
At close: Aug 15, 2025, 3:59 PM
2.89
0.87%
After-hours: Aug 15, 2025, 07:11 PM EDT

CalciMedica Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 60K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a 15K 30K 15K 15K 15K 19K 12K 14K 13K n/a 185K 217K 213K 136K 136K n/a n/a
Gross Profit
n/a -15K 30K -15K -15K -15K -19K -12K -14K -13K n/a -185K -217K -213K -136K -136K n/a n/a
Operating Income
-6.62M -6.5M -6.17M -5.74M -6.53M -5.77M -4.32M -4.83M -6.58M -22.34M -7.71M -9.98M -8.3M -10.18M -8.7M -8.02M -7.74M -11.49M
Interest Income
220K n/a n/a n/a n/a n/a n/a n/a n/a n/a 309K 171K 60K 35K 26K 28K 33K 39K
Pretax Income
-5.96M -5.04M -4.26M -5.62M -3.95M 130K -4.15M -4.62M -6.3M -19.29M -7.4M -9.81M -8.24M -10.15M -8.68M -7.99M -7.71M -11.45M
Net Income
-5.96M -5.04M -4.26M -5.62M -3.95M 130K -4.15M -4.62M -6.3M -19.29M -7.4M -9.81M -8.24M -10.15M -8.68M -7.99M -7.71M -11.45M
Selling & General & Admin
2.57M 2.27M 2.34M 2.19M 2.37M 2.82M 1.54M 2.06M 2.77M 15.85M 6.43M 4.3M 4.24M 4.13M 4.43M 4M 3.58M 5.04M
Research & Development
4.05M 4.22M 3.83M 3.55M 4.16M 2.94M 2.78M 2.77M 3.81M 6.49M 749K 3.25M 4.06M 6.06M 4.27M 4.02M 4.17M 6.45M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a -116K n/a -49K -29K n/a n/a n/a n/a n/a
Operating Expenses
6.62M 6.5M 6.17M 5.74M 6.53M 5.77M 4.32M 4.83M 6.58M 22.34M 7.18M 7.55M 8.3M 10.18M 8.7M 8.02M 7.74M 11.49M
Interest Expense
324K -447K n/a n/a n/a n/a n/a n/a n/a n/a n/a 171K 60K 35K 26K 28K 33K 39K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
6.62M 6.5M 6.17M 5.74M 6.53M 5.77M 4.32M 4.83M 6.58M 22.34M 7.18M 7.55M 8.3M 10.18M 8.7M 8.02M 7.74M 11.49M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 2.26M -125K -91K n/a n/a n/a n/a
Shares Outstanding (Basic)
15B 14.12M 12.76M 11.13M 11.13M 9.75M 5.74M 5.67M 5.66M 820K 1.54M 1.53M 1.53M 1.53M 1.52M 1.52M 1.51M 1.5M
Shares Outstanding (Diluted)
15B 14.12M 12.76M 11.13M 11.13M 10.05M 5.74M 5.67M 5.66M 820K 1.54M 1.53M 1.53M 1.53M 1.52M 1.52M 1.51M 1.5M
EPS (Basic)
-0.4 -0.36 -0.33 -0.5 -0.36 0.01 -0.72 -0.81 -1.11 -23.52 -4.79 -6.39 -5.37 -6.61 -5.69 -5.25 -5.1 -7.63
EPS (Diluted)
-0.4 -0.36 -0.33 -0.5 -0.36 0.01 -0.72 -0.81 -1.11 -23.52 -4.79 -6.39 -5.37 -6.61 -5.69 -5.25 -5.1 -7.63
EBITDA
-6.62M -6.5M -4.24M -5.72M -6.53M -5.75M -472K -4.82M -6.57M -22.33M -6.66M -5.02M -8.3M -10.06M -8.56M -7.88M -7.61M -10.02M
EBIT
-5.63M -4.59M -4.26M -5.74M -6.53M -5.77M -491K -4.83M -6.58M -22.34M -7.18M -3.29M -3.59M -4.21M -8.7M -8.02M -7.74M -10.14M
Depreciation & Amortization
n/a 15K 14K 15K 14K 15K 19K 12K 14K 13K 1.06M 185K 217K 213K 136K 136K 129K 118K